Impact of environmentally induced hypothermia on fentanyl and norfentanyl pharmacokinetics following intravenous administration to Wistar rats Publication Impact of environmentally induced hypothermia on fentanyl and norfentanyl pharmacokinetics following intravenous administration to Wistar rats Learn how severe hypothermia increases fentanyl exposure and reduces clearance, with higher norfentanyl levels using…CertaraJanuary 23, 2026
Milliliters, Milligrams, and Moles: Keeping Up with Units in NCA Webinar Milliliters, Milligrams, and Moles: Keeping Up with Units in NCA Danielle PillsburyJanuary 22, 2026
Non-compartmental analysis of statin pharmacokinetics in pharmacogenetics research Webinar Non-compartmental analysis of statin pharmacokinetics in pharmacogenetics research CertaraJanuary 22, 2026
Combining Aggregate Data and Individual Patient Data in Model-Based Meta-Analysis: An Illustrative Case Study of Tofacitinib in Rheumatoid Arthritis Patients Publication Combining Aggregate Data and Individual Patient Data in Model-Based Meta-Analysis: An Illustrative Case Study of Tofacitinib in Rheumatoid Arthritis Patients This article explores how model-based meta-analysis (MBMA) performs when combining aggregate data and individual patient…CertaraJanuary 22, 2026
Model-Based Meta-Analysis (MBMA), Quantitative Systems Pharmacology (QSP), and Advanced Modeling in Early Reimbursement Strategy On-Demand Webinar Model-Based Meta-Analysis (MBMA), Quantitative Systems Pharmacology (QSP), and Advanced Modeling in Early Reimbursement Strategy Watch this on-demand webinar to learn how model-based meta-analysis (MBMA), quantitative systems pharmacology (QSP), and…CertaraJanuary 22, 2026
Adaptive clinical trials in oncology: Meeting the challenge of Project Optimus Blog Adaptive clinical trials in oncology: Meeting the challenge of Project Optimus Leveraging adaptive clinical trial designs in oncology can accelerate drug development, while following the FDA…CertaraJanuary 16, 2026
CHI ADC Webinar Series: From First-in-Human Dose Selection to Label Optimization, Commercial Expansion, and Market Access Webinar CHI ADC Webinar Series: From First-in-Human Dose Selection to Label Optimization, Commercial Expansion, and Market Access CertaraJanuary 14, 2026
Regulatory Horizons: Strategic Global Insights & 2026 Outlook from Former Leaders of Major Regulatory Agencies On-Demand Webinar Regulatory Horizons: Strategic Global Insights & 2026 Outlook from Former Leaders of Major Regulatory Agencies Watch this on-demand webinar featuring former regulators as they share global regulatory trends and clinical…CertaraJanuary 14, 2026
Evaluation of a New Formulation That Improves the Bioavailability and Food Effect of Abiraterone: An Open-Label, Crossover, Randomized, Controlled, Phase I Clinical Trial Publication Evaluation of a New Formulation That Improves the Bioavailability and Food Effect of Abiraterone: An Open-Label, Crossover, Randomized, Controlled, Phase I Clinical Trial Find out how RL001 delivers >1000 mg tablet exposure with reduced food effect and improved…CertaraJanuary 1, 2026